Loos, France

Alzprotect


USPTO Granted Patents = 5


Trademarks = 1

Forward Citations = 2

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Cécilia Estrella (5 out of 5 patents)

silverMedal Philippe Verwaerde (5 out of 5 patents)

bronzeMedal Nicolas Sergeant (4 out of 12 patents)

4.  Mathieu Barrier (4 out of 4 patents)

5.  Patricia Melnyk (4 out of 10 patents)

6.  Stéphane Burlet (3 out of 3 patents)

7.  Luc Buee (3 out of 8 patents)

8.  Pascal Carato (1 out of 3 patents)

9.  Emilie Nguyen (1 out of 1 patent)

10.  Stephane Burlet (1 out of 2 patents)

11.  Noëlle Callizot (1 out of 3 patents)

12.  Saurabh Chitre (3 patents)

13.  Gavin Pringle (1 patent)

14.  Cyrille Brantis (0 patent)

15.  Jonathan Loughrey (1 patent)


5 patents:

Company Overview
Alzprotect is a biopharmaceutical company focused on developing innovative drug candidates for the treatment of neurodegenerative diseases, with a primary focus on Alzheimer's disease. Their mission is to provide groundbreaking therapies that offer hope to patients and their families. Alzprotect's team of experts are dedicated to advancing research and clinical development to address the growing need for effective treatments in this area.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#3 in Loos

#2,865 in France

Loos, FR
Loos, France
Forward Citations = 2

14 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alzprotect. Retrieved from https://idiyas.com/company/alzprotect

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…